Pharma
Clinical insights: Respiratory care digital innovation opportunities
Co-authored by Dr Bipin Patel, CEO, electronRx, Cambridge, UK and Dr Hiromichi Yamaguchi, Yamaguchi Respiratory Clinic and Dermatology, Tokyo, Japan. ...
From complexity to clarity: analytics in cell and gene therapy
Cell and gene therapies (CGTs) have redefined the treatment landscape, but their development and manufacturing remain uniquely challenging. They involve variable starting materials and complex, small-scale processes. As the field pushes for faster development, scalable manufacturing and...
NPZ Technology and CCV to showcase cross-border innovation at Cambridge Tech Week 2025
As Innovation Zone Sponsors at Cambridge Tech Week 2025, NPZ Technology Ltd and Cambridge Collaborative Ventures Ltd (CCV) will host an exhibition zone in Innovation Alley, featuring five cross-border innovation companies in digital health, VR, robotics, and AI. ...
Radiotherapy and surgical ablation technologies for cancer treatment
Radiotherapy, or radiation ablation, has evolved significantly since its inception. Ongoing technological advancements have the potential to position radiotherapy as a first-line “surgical” treatment for solid tumours by enhancing its precision and efficacy. Further advancements in real...
Panel Session & Innovation Tour at PA Consulting, 2nd Sept
Join Cambridge Network for an exclusive visit to PA Consulting, a global innovation and transformation consultancy where ingenious ideas are turned into physical and digital reality.Panel Session: ‘Secrets to a Successful Start-Up No One Talks About’ ...
Preventing patient hospitalisation through better stratification and timely intervention
In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management. One powerful strategy to achieve this is patient stratification—classifying patients into different groups based on their vulnerability to hos...
Milner Therapeutics Institute featured in AstraZeneca-University of Cambridge partnership impact report
The Milner Therapeutics Institute is delighted to be featured in a new report celebrating a decade of partnership and impact between AstraZeneca and the University of Cambridge ...
PhoreMost demonstrates new approach to rationalise molecular glue drug discovery
Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space ...
25 years of Guardtech: Isopod Manufacturing Director Michael Burton Q&A
One of the Group’s longest-serving superstars gives his thoughts on why the Guardtech Group are pushing the boundaries of small-scale cleanroom provision with their rapid-assembly pod systems ...
IOSH Approved Biological Safety - Management and Practice (2 day course)
AudienceThe course is predominantly aimed at those fairly new to the role and mostly focuses on work at ACDP containment levels 1 and 2 and work with GMOs. However, experienced BSO will also benefit from the course. DurationA two day course. ObjectivesTo improve your knowledge...